This scientific-industrial event aims to promote and strengthen partnerships between public and private actors, helping them to identify needs and develop new solutions.
Under the chairmanship of David Lehmann, Director of Strategic Foresight, R&D BioMonitoring, Merck Life Science, decision-makers and players in biomedicine will meet for two days of conferences, round tables, feedback and technical and collaborative workshops, focusing on the challenges of the “time to release” of biotherapies.
Topics discussed will include:
- Environmental monitoring
- In-process testing
- Release testing
Meet our team at Booth 9 and find out more about our biopharmaceutical testing solutions.
For further information, please contact: